Kaufman, Bella <br/><br/>
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2015 
 - 244-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2014.56.2728  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Germ-Line Mutation<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Pancreatic Neoplasms--drug therapy<br/>Phthalazines--administration & dosage<br/>Piperazines--administration & dosage<br/>Prospective Studies<br/>Prostatic Neoplasms--drug therapy<br/>Treatment Outcome